Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

LCE2C Inhibitors

LCE2C inhibitors are a class of chemical compounds that focus on the inhibition of the Late Cornified Envelope 2C (LCE2C) protein. This protein, a member of the Late Cornified Envelope (LCE) protein family, plays a crucial role in the formation of the cornified envelope of the epidermis. The cornified envelope is an essential component of the skin's barrier function, providing protection against environmental factors and maintaining homeostasis. The LCE2C inhibitors, through their specific interaction with the LCE2C protein, influence this process. The exact mechanism of action of these inhibitors involves binding to the LCE2C protein, thereby modulating its function. This interaction is typically characterized by a high degree of specificity, ensuring that the inhibitors primarily target the LCE2C protein with minimal effects on other proteins in the LCE family. Some inhibitors work indirectly.

The chemical structure of LCE2C inhibitors is diverse, encompassing a range of molecular frameworks. This diversity allows for varying degrees of affinity and specificity towards the LCE2C protein. The design and development of these inhibitors often involve advanced techniques in chemistry and computational modeling to optimize their interaction with the target protein. This includes the fine-tuning of their physicochemical properties, such as solubility, stability, and molecular size, to enhance their effectiveness in modulating the LCE2C protein. Moreover, the study of LCE2C inhibitors also contributes significantly to the broader understanding of skin biology, particularly in the context of the epidermal differentiation complex (EDC), where the LCE gene family is located. Research in this area not only deepens our knowledge of the molecular mechanisms underlying skin barrier formation but also sheds light on the intricate network of proteins involved in epidermal homeostasis and function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Calcipotriol

112965-21-6sc-203537
sc-203537A
10 mg
50 mg
$203.00
$832.00
4
(1)

As a Vitamin D analog, Calcipotriol modulates keratinocyte proliferation and differentiation, thereby reducing LCE2C levels.

Tazarotene

118292-40-3sc-220193
10 mg
$103.00
(0)

A retinoid that normalizes keratinocyte differentiation, Tazarotene lowers expression of LCE2C in the epidermis.

Corticosterone

50-22-6sc-300391
sc-300391A
100 mg
500 mg
$58.00
$110.00
2
(2)

Corticosteroids inhibit inflammation and modulate skin cell growth, leading to decreased LCE2C expression in skin lesions.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate impedes cell proliferation in psoriatic plaques, which correlates with a reduction in LCE2C expression.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporin A indirectly lowers LCE2C levels by reducing keratinocyte hyperproliferation.

FK-506

104987-11-3sc-24649
sc-24649A
5 mg
10 mg
$78.00
$151.00
9
(1)

FK-506 diminishes LCE2C expression by downregulating inflammatory pathways in the skin.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR signaling, which can indirectly reduce the hyperproliferative state that upregulates LCE2C.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea suppresses DNA synthesis in rapidly dividing cells, thus potentially decreasing LCE2C levels in hyperproliferative disorders.

Salicylic acid

69-72-7sc-203374
sc-203374A
sc-203374B
100 g
500 g
1 kg
$47.00
$94.00
$119.00
3
(1)

Salicylic Acid, as a keratolytic agent, can reduce the thickness of plaques and indirectly diminish LCE2C protein expression.

Imiquimod

99011-02-6sc-200385
sc-200385A
100 mg
500 mg
$67.00
$284.00
6
(1)

Imiquimod activates immune responses leading to alterations in keratinocyte function, which can reduce LCE2C levels.